MCP
GILD icon

Mirador Capital Partners’s Gilead Sciences GILD Stock Holding History

Mirador Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
14,099
-166
-1% -$21.9K 0.22% 73
2026
Q1 		$1.99M Buy
14,265
+208
+1% +$29.1K 0.28% 61
2025
Q4 		$1.73M Sell
14,057
-66
-0.5% -$8.02K 0.24% 71
2025
Q3 		$1.57M Sell
14,123
-161
-1% -$18.3K 0.22% 75
2025
Q2 		$1.58M Buy
14,284
+580
+4% +$61.7K 0.26% 69
2025
Q1 		$1.54M Sell
13,704
-19
-0.1% -$1.96K 0.27% 61
2024
Q4 		$1.27M Buy
13,723
+528
+4% +$47.5K 0.23% 70
2024
Q3 		$1.11M Buy
13,195
+443
+3% +$33.8K 0.2% 77
2024
Q2 		$875K Buy
12,752
+755
+6% +$50.4K 0.16% 82
2024
Q1 		$879K Buy
11,997
+853
+8% +$65.6K 0.17% 95
2023
Q4 		$903K Buy
11,144
+744
+7% +$57.9K 0.19% 83
2023
Q3 		$779K Buy
10,400
+711
+7% +$54.7K 0.18% 91
2023
Q2 		$747K Sell
9,689
-27
-0.3% -$2.15K 0.18% 97
2023
Q1 		$806K Sell
9,716
-4,971
-34% -$412K 0.19% 81
2022
Q4 		$1.26M Buy
14,687
+75
+0.5% +$5.94K 0.3% 66
2022
Q3 		$901K Sell
14,612
-149
-1% -$9.4K 0.22% 74
2022
Q2 		$912K Buy
14,761
+624
+4% +$38.6K 0.22% 80
2022
Q1 		$840K Buy
14,137
+1,867
+15% +$119K 0.17% 96
2021
Q4 		$891K Buy
12,270
+227
+2% +$15.6K 0.19% 98
2021
Q3 		$841K Sell
12,043
-16
-0.1% -$1.12K 0.19% 103
2021
Q2 		$830K Sell
12,059
-24,992
-67% -$1.67M 0.19% 103
2021
Q1 		$2.4M Buy
37,051
+1,388
+4% +$89.5K 0.61% 54
2020
Q4 		$2.08M Buy
35,663
+4,974
+16% +$300K 0.57% 57
2020
Q3 		$1.94M Buy
30,689
+356
+1% +$24.7K 0.6% 50
2020
Q2 		$2.33M Buy
30,333
+502
+2% +$38.5K 0.87% 37
2020
Q1 		$2.31M Buy
29,831
+8,085
+37% +$559K 0.97% 33
2019
Q4 		$1.41M Buy
21,746
+12,070
+125% +$786K 0.57% 54
2019
Q3 		$613K Buy
9,676
+143
+2% +$9.35K 0.27% 84
2019
Q2 		$644K Sell
9,533
-95
-1% -$6.25K 0.32% 74
2019
Q1 		$626K Buy
9,628
+3,738
+63% +$248K 0.34% 71
2018
Q4 		$368K Sell
5,890
-178
-3% -$12.4K 0.23% 84
2018
Q3 		$469K Buy
6,068
+1
+0% +$76 0.23% 88
2018
Q2 		$430K Sell
6,067
-4,943
-45% -$349K 0.23% 88
2018
Q1 		$795K Buy
11,010
+171
+2% +$13.6K 0.55% 51
2017
Q4 		$777K Buy
10,839
+4,984
+85% +$378K 0.43% 68
2017
Q3 		$489K Sell
5,855
-60
-1% -$4.59K 0.29% 77
2017
Q2 		$433K Sell
5,915
-885
-13% -$58.9K 0.27% 80
2017
Q1 		$462K Buy
+6,800
New +$478K 0.34% 76

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Mirador Capital Partners's GILD Position: Q2 2026 in Review

Mirador Capital Partners reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $21.9K and leaving 14,099 shares worth $1.78M. The position accounts for 0.22% of the portfolio, ranked #73.

Mirador Capital Partners first reported a position in GILD in Q1 2017 and has held it in 38 quarters since. The position peaked at $2.4M in Q1 2021. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mirador Capital Partners held 14,099 shares of Gilead Sciences worth $1.78M as of Q2 2026.
  • Mirador Capital Partners sold 166 Gilead Sciences shares in Q2 2026, an estimated $21.9K.
  • Gilead Sciences made up 0.22% of Mirador Capital Partners's portfolio in Q2 2026, its #73 holding.
  • Mirador Capital Partners first reported a position in Gilead Sciences in Q1 2017 and has held it in 38 quarters since.
  • Mirador Capital Partners's Gilead Sciences position peaked at $2.4M in Q1 2021.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.